DOI:
10.1055/s-00000097
Deutsche Zeitschrift für Onkologie
LinksClose Window
References
Schmid P, Cortes J, Pusztai L. et al.
KEYNOTE-522 Investigators. Pembrolizumab for early triple negative breast
cancer.
N Engl J Med 2020;
382: 810-821
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.